Back

A GATA2-PROX1-FOXC2 regulatory axis integrates shear stress signaling with lymphatic vascular development

Geng, X.;Mahamud, M.;Rosikiewicz, W.;Ent, M.;Zawieja, S.;Chen, H.;Cleuren, A.;Li, C.;Davis, M.;Srinivasan, R.

2026-06-26 Developmental Biology
10.64898/2026.06.25.734612 bioRxiv
Show abstract

The two-hit hypothesis provides a novel framework for incompletely penetrant vascular disorders. Emberger syndrome, caused by heterozygous loss-of-function mutations in mechanosensitive transcription factor (TF) GATA2, is associated with lymphedema in a subset of patients, suggesting that modifiers influence disease development. Heterozygous loss-of-function mutations in mechanosensitive TF FOXC2 also cause lymphedema. Complete deletion of either factor in lymphatic endothelial cells (LECs) causes severe, overlapping defects, including complete loss of lymphatic valves, whereas single heterozygous mutants exhibit milder phenotypes, suggesting genetic buffering. However, whether GATA2 and FOXC2 interact with each other and with shear stress-dependent transcriptional programs remains unclear. Here, we show that Gata2+/-;Foxc2+/- mice develop profound lymphatic vascular defects, including absent lymphatic valves, perinatal lethality, and valve dysfunction, revealing dosage-dependent cooperation between GATA2 and FOXC2. Using a Cre-dependent model of LEC-specific GATA2 overexpression, we found that increased GATA2 dosage downregulated PROX1 and disrupted lymphatic vascular development. ATAC-seq and bulk RNA-seq of shear-exposed human LECs showed that PROX1 governs shear-responsive genes, including KLF2 and KLF4, whereas FOXC2 modulates PROX1-dependent and independent gene subsets. Together, these findings identify PROX1 as a central integrator of shear stress-responsive transcriptional programs and reveal that balanced GATA2 and FOXC2 dosage preserves this network during lymphatic vascular development.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 13%
12.9%
2
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 0.2%
10.6%
3
eLife
5828 papers in training set
Top 16%
6.7%
4
Developmental Cell
196 papers in training set
Top 0.5%
6.3%
5
Journal of Clinical Investigation
179 papers in training set
Top 0.6%
5.5%
6
JCI Insight
277 papers in training set
Top 1%
5.5%
7
Science Advances
1243 papers in training set
Top 7%
4.3%
50% of probability mass above
8
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 12%
4.3%
9
Development
497 papers in training set
Top 2%
3.4%
10
Cell Reports
1498 papers in training set
Top 12%
3.2%
11
Journal of Experimental Medicine
119 papers in training set
Top 1%
2.4%
12
Journal of Cell Biology
392 papers in training set
Top 2%
2.1%
13
Science Translational Medicine
127 papers in training set
Top 2%
1.7%
14
Scientific Reports
3612 papers in training set
Top 54%
1.7%
15
Nature Cardiovascular Research
33 papers in training set
Top 0.5%
1.7%
16
The EMBO Journal
309 papers in training set
Top 4%
1.4%
17
Cardiovascular Research
37 papers in training set
Top 0.9%
1.1%
18
The FASEB Journal
194 papers in training set
Top 4%
1.1%
19
Circulation Research
47 papers in training set
Top 1.0%
1.1%
20
PLOS ONE
5266 papers in training set
Top 57%
1.1%
21
Advanced Science
286 papers in training set
Top 8%
1.1%
22
PLOS Genetics
862 papers in training set
Top 11%
1.0%
23
Angiogenesis
14 papers in training set
Top 0.1%
1.0%
24
Nature Genetics
286 papers in training set
Top 4%
1.0%
25
Communications Biology
993 papers in training set
Top 30%
0.8%
26
Circulation
74 papers in training set
Top 2%
0.8%
27
Cell
431 papers in training set
Top 11%
0.6%
28
Journal of Investigative Dermatology
49 papers in training set
Top 0.7%
0.6%
29
Matrix Biology
29 papers in training set
Top 0.7%
0.6%
30
GENETICS
483 papers in training set
Top 5%
0.6%